Drug intelligence / Profile preview

JieYuSuFei

Development stage: Preclinical
Lead developer: Xiyuan Hospital
Administration: Oral

Overview

JieYuSuFei (also referred to as "Jieyu Sufei Decoctio") is a traditional Chinese medicine formulation studied for the treatment of chronic persistent stage bronchial asthma. It is used as part of an integrative approach in Traditional Chinese Medicine (TCM) and is administered as a decoction. The precise herbal composition, mechanism of action, and pharmacological targets are not specified in available clinical trial records. Its use aligns with TCM principles rather than Western pharmacology, and it is not classified under standard pharmaceutical drug categories.

Brand names: JieYuSuFei
Other names: Jieyu Sufei Decoctio

Beyond the preview

Go deeper on JieYuSuFei.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JieYuSuFei.

Explore the full profile